文献速递银屑病与炎症性皮肤病

Omega-3多不饱和脂肪酸在银屑病细胞组织工程皮肤模型中的生物学活性研究

Investigation of Omega-3 Polyunsaturated Fatty Acid Biological Activity in a Tissue-Engineered Skin Model Involving Psoriatic Cells.
PubMed 文献 · J Invest Dermatol · 2021-04-20

该研究利用组织工程自组装法构建含健康或银屑病细胞的皮肤模型,比较补充10 μM α-亚麻酸(ALA)与常规培养基的效果。结果显示ALA降低银屑病替代物角质形成细胞增殖并改善其表皮分化,ALA被整合入表皮磷脂并代谢为长链n-3多不饱和脂肪酸,同时减少n-6多不饱和脂肪酸脂质介质水平,细胞外信号调节激酶1和2是ALA补充后激活最明显的信号转导介质。

要点

  • ALA降低银屑病皮肤模型角质形成细胞增殖并改善表皮分化。
  • ALA整合入表皮磷脂并代谢为EPA和n-3 DPA。
  • ALA减少n-6多不饱和脂肪酸脂质介质如LTB4水平。

核心结论

  • ALA通过正常化角质形成细胞增殖和分化,降低银屑病替代物的病理表型。

研究设计与样本

  • 采用组织工程自组装法构建含健康或银屑病细胞的三维皮肤模型,比较补充10 μM ALA的培养基与常规未补充培养基。

主要发现

  • ALA降低银屑病替代物中Ki67染色并增加FLG和loricrin蛋白表达。
  • 添加的ALA被整合入表皮磷脂并代谢为长链n-3多不饱和脂肪酸,主要为EPA和n-3 DPA。
  • ALA补充增加EPA衍生物15-HEPE和18-HEPE水平,并降低n-6多不饱和脂肪酸脂质介质9-HODE、12-HETE和LTB4水平。
  • ALA补充后细胞外信号调节激酶1和2是激活最明显的激酶。

临床怎么用

  • 提示ALA可能通过调节角质形成细胞增殖分化和脂质介质谱改善银屑病表皮病理,但需临床研究验证。

局限性

  • 研究为体外三维皮肤模型,不能完全反映体内银屑病复杂微环境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical studies have shown that diets enriched with omega-3 (also know as n-3) polyunsaturated fatty acids could relieve the symptoms of patients with psoriasis. However, the mechanisms involved remain poorly understood. The aim of this study was to investigate the effects of α-linolenic acid (ALA) on the proliferation and differentiation of psoriatic keratinocytes in a three-dimensional skin model. Skin models featuring healthy (healthy substitute) or psoriatic (psoriatic substitute) cells were engineered by the self-assembly method of tissue engineering using a culture medium supplemented with 10 μM ALA in comparison with the regular unsupplemented medium. ALA decreased keratinocyte proliferation and improved psoriatic substitute epidermal differentiation, as measured by decreased Ki67 staining and increased protein expression of FLG and loricrin. The added ALA was notably incorporated into the epidermal phospholipids and metabolized into long-chain n-3 polyunsaturated fatty acids, mainly eicosapentaenoic acid and n-3 docosapentaenoic acid. ALA supplementation led to increased levels of eicosapentaenoic acid derivatives (15-hydroxyeicosapentaenoic acid and 18-hydroxyeicosapentaenoic acid) as well as a decrease in levels of omega-6 (also know as n-6) polyunsaturated fatty acid lipid mediators (9-hydroxyoctadecadienoic acid, 12-hydroxyeicosatetraenoic acid, and leukotriene B4). Furthermore, the signal transduction mediators extracellular signal‒regulated kinases 1 and 2 were the kinases most activated after ALA supplementation. Taken together, these results show that ALA decreases the pathologic phenotype of psoriatic substitutes by normalizing keratinocyte proliferation and differentiation in vitro.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Simard M, Rioux G, Morin S, et al. Investigation of Omega-3 Polyunsaturated Fatty Acid Biological Activity in a Tissue-Engineered Skin Model Involving Psoriatic Cells. J Invest Dermatol. 2021. PMID: 33857488. doi:10.1016/j.jid.2021.02.755

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。